Does CARBOPLATIN Cause Immune-mediated hepatitis? 213 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 213 reports of Immune-mediated hepatitis have been filed in association with CARBOPLATIN (Carboplatin). This represents 0.3% of all adverse event reports for CARBOPLATIN.
213
Reports of Immune-mediated hepatitis with CARBOPLATIN
0.3%
of all CARBOPLATIN reports
32
Deaths
124
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From CARBOPLATIN?
Of the 213 reports, 32 (15.0%) resulted in death, 124 (58.2%) required hospitalization, and 38 (17.8%) were considered life-threatening.
Is Immune-mediated hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 213 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOPLATIN Cause?
Off label use (6,100)
Neutropenia (5,314)
Anaemia (5,312)
Febrile neutropenia (4,888)
Nausea (4,588)
Disease progression (4,538)
Thrombocytopenia (4,483)
Malignant neoplasm progression (4,177)
Diarrhoea (4,154)
Dyspnoea (3,494)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
BEVACIZUMAB (108)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
TREMELIMUMAB (51)
Which CARBOPLATIN Alternatives Have Lower Immune-mediated hepatitis Risk?
CARBOPLATIN vs CARBOPROST TROMETHAMINE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES